Anti-hemolytic agent emulsions
AssigneeBaxter Travenol Laboratories, Inc.
InventorsRichard G. Buckles, Jan W. Garber
Life of this patent
Estimating the term…
Abstract
Blood may be stored in vitro for a period of days at a reduced temperature in the container which also includes a sufficient quantity of an emulsion of anti-hemolytic agent to cause a reduction in the hemolysis of the stored blood, when compared with blood under similar storage conditions to the absence of the emulsion. Preferably, the emulsion may include a fatty ester containing at least two ester linkages each comprising a fatty hydrocarbon group, with the emulsion containing sufficient hemo-compatible surfactant to stabilize the emulsion.
Claims10
A blood storage container made of a hemocompatible material, said container also including sufficient quantity of a dispersed phosphate ester containing at least two ester linkages comprising fatty hydrocarbon groups, each of six to 12 carbon atoms, said ester linkages being bonded to the same phosphorous atom, said phosphate ester being present in sufficient amount to cause a reduction in the hemolysis of blood stored in said container for a period of 21 days, when compared with blood under similar storage conditions in the absence of said phosphate ester, said blood container also containing a blood nutrient and stabilizing agent.
The method of storage of blood in vitro for a period of more than two days at a reduced temperature in a hemocompatible container which also contains sufficient quantity of a dispersed phosphate ester containing a plurality of ester linkages comprising fatty hydrocarbon groups of 4 to 12 carbon atoms each, said ester linkages being bonded to the same phosphorous atom, in sufficient concentration to cause a reduction in the hemolysis of the stored blood, when compared with blood under similar storage conditions in the absence of said phosphate ester.
Dependencies are inferred from the claim text.